Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus

Karen Rulli, Jack Lenz, Laura S. Levy

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A time course analysis of SL3-3 murine leukemia virus (SL3) infection in thymus and bone marrow of NIH/Swiss mice was performed to assess changes that occur during the early stages of progression to lymphoma. Virus was detectable in thymocytes, bone marrow, and spleen as early as 1 to 2 weeks postinoculation (p.i.). In bone marrow, virus infection was detected predominantly in immature myeloid or granulocytic cells. Flow cytometry revealed significant reductions of the Ter-119+ and Mac-1+ populations, and significant expansions of the Gr-1+ and CD34+ populations, between 2 and 4 weeks p.i. Analysis of colony-forming potential confirmed these findings. In the thymus, SL3 replication was associated with significant disruption in thymocyte subpopulation distribution between 4 and 7 weeks p.i. A significant thymic regression was observed just prior to the clonal outgrowth of tumor cells. Proviral long terminal repeats (LTRs) with increasing numbers of enhancer repeats were observed to accumulate exclusively in the thymus during the first 8 weeks p.i. Observations were compared to the early stages of infection with a virtually nonpathogenic SL3 mutant, termed SL3ΔMyb5, which was shown by real-time PCR to be replication competent. Comparison of SL3 with SL3ΔMyb5 implicated certain premalignant changes in tumorigenesis, including (i) increased proportions of Gr-1+ and CD34+ bone marrow progenitors, (ii) a significant increase in the proportion of CD4- CD8- thymocytes, (iii) thymic regression prior to tumor outgrowth, and (iv) accumulation of LTR enhancer variants. A model in which disrupted bone marrow hematopoiesis and thymopoiesis contribute to the development of lymphoma in the SL3-infected animal is discussed.

Original languageEnglish (US)
Pages (from-to)2363-2374
Number of pages12
JournalJournal of Virology
Volume76
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Murine leukemia virus
Murine Leukemia Viruses
hematopoiesis
Hematopoiesis
bone marrow
Bone Marrow
thymocytes
Thymocytes
Thymus Gland
Infection
terminal repeat sequences
infection
Terminal Repeat Sequences
Virus Diseases
lymphoma
Lymphoma
viruses
carcinogenesis
Population
flow cytometry

ASJC Scopus subject areas

  • Immunology

Cite this

Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus. / Rulli, Karen; Lenz, Jack; Levy, Laura S.

In: Journal of Virology, Vol. 76, No. 5, 2002, p. 2363-2374.

Research output: Contribution to journalArticle

@article{7f4d7d3628da4701b3d040d5e1921123,
title = "Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus",
abstract = "A time course analysis of SL3-3 murine leukemia virus (SL3) infection in thymus and bone marrow of NIH/Swiss mice was performed to assess changes that occur during the early stages of progression to lymphoma. Virus was detectable in thymocytes, bone marrow, and spleen as early as 1 to 2 weeks postinoculation (p.i.). In bone marrow, virus infection was detected predominantly in immature myeloid or granulocytic cells. Flow cytometry revealed significant reductions of the Ter-119+ and Mac-1+ populations, and significant expansions of the Gr-1+ and CD34+ populations, between 2 and 4 weeks p.i. Analysis of colony-forming potential confirmed these findings. In the thymus, SL3 replication was associated with significant disruption in thymocyte subpopulation distribution between 4 and 7 weeks p.i. A significant thymic regression was observed just prior to the clonal outgrowth of tumor cells. Proviral long terminal repeats (LTRs) with increasing numbers of enhancer repeats were observed to accumulate exclusively in the thymus during the first 8 weeks p.i. Observations were compared to the early stages of infection with a virtually nonpathogenic SL3 mutant, termed SL3ΔMyb5, which was shown by real-time PCR to be replication competent. Comparison of SL3 with SL3ΔMyb5 implicated certain premalignant changes in tumorigenesis, including (i) increased proportions of Gr-1+ and CD34+ bone marrow progenitors, (ii) a significant increase in the proportion of CD4- CD8- thymocytes, (iii) thymic regression prior to tumor outgrowth, and (iv) accumulation of LTR enhancer variants. A model in which disrupted bone marrow hematopoiesis and thymopoiesis contribute to the development of lymphoma in the SL3-infected animal is discussed.",
author = "Karen Rulli and Jack Lenz and Levy, {Laura S.}",
year = "2002",
doi = "10.1128/jvi.76.5.2363-2374.2002",
language = "English (US)",
volume = "76",
pages = "2363--2374",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus

AU - Rulli, Karen

AU - Lenz, Jack

AU - Levy, Laura S.

PY - 2002

Y1 - 2002

N2 - A time course analysis of SL3-3 murine leukemia virus (SL3) infection in thymus and bone marrow of NIH/Swiss mice was performed to assess changes that occur during the early stages of progression to lymphoma. Virus was detectable in thymocytes, bone marrow, and spleen as early as 1 to 2 weeks postinoculation (p.i.). In bone marrow, virus infection was detected predominantly in immature myeloid or granulocytic cells. Flow cytometry revealed significant reductions of the Ter-119+ and Mac-1+ populations, and significant expansions of the Gr-1+ and CD34+ populations, between 2 and 4 weeks p.i. Analysis of colony-forming potential confirmed these findings. In the thymus, SL3 replication was associated with significant disruption in thymocyte subpopulation distribution between 4 and 7 weeks p.i. A significant thymic regression was observed just prior to the clonal outgrowth of tumor cells. Proviral long terminal repeats (LTRs) with increasing numbers of enhancer repeats were observed to accumulate exclusively in the thymus during the first 8 weeks p.i. Observations were compared to the early stages of infection with a virtually nonpathogenic SL3 mutant, termed SL3ΔMyb5, which was shown by real-time PCR to be replication competent. Comparison of SL3 with SL3ΔMyb5 implicated certain premalignant changes in tumorigenesis, including (i) increased proportions of Gr-1+ and CD34+ bone marrow progenitors, (ii) a significant increase in the proportion of CD4- CD8- thymocytes, (iii) thymic regression prior to tumor outgrowth, and (iv) accumulation of LTR enhancer variants. A model in which disrupted bone marrow hematopoiesis and thymopoiesis contribute to the development of lymphoma in the SL3-infected animal is discussed.

AB - A time course analysis of SL3-3 murine leukemia virus (SL3) infection in thymus and bone marrow of NIH/Swiss mice was performed to assess changes that occur during the early stages of progression to lymphoma. Virus was detectable in thymocytes, bone marrow, and spleen as early as 1 to 2 weeks postinoculation (p.i.). In bone marrow, virus infection was detected predominantly in immature myeloid or granulocytic cells. Flow cytometry revealed significant reductions of the Ter-119+ and Mac-1+ populations, and significant expansions of the Gr-1+ and CD34+ populations, between 2 and 4 weeks p.i. Analysis of colony-forming potential confirmed these findings. In the thymus, SL3 replication was associated with significant disruption in thymocyte subpopulation distribution between 4 and 7 weeks p.i. A significant thymic regression was observed just prior to the clonal outgrowth of tumor cells. Proviral long terminal repeats (LTRs) with increasing numbers of enhancer repeats were observed to accumulate exclusively in the thymus during the first 8 weeks p.i. Observations were compared to the early stages of infection with a virtually nonpathogenic SL3 mutant, termed SL3ΔMyb5, which was shown by real-time PCR to be replication competent. Comparison of SL3 with SL3ΔMyb5 implicated certain premalignant changes in tumorigenesis, including (i) increased proportions of Gr-1+ and CD34+ bone marrow progenitors, (ii) a significant increase in the proportion of CD4- CD8- thymocytes, (iii) thymic regression prior to tumor outgrowth, and (iv) accumulation of LTR enhancer variants. A model in which disrupted bone marrow hematopoiesis and thymopoiesis contribute to the development of lymphoma in the SL3-infected animal is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0036168066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036168066&partnerID=8YFLogxK

U2 - 10.1128/jvi.76.5.2363-2374.2002

DO - 10.1128/jvi.76.5.2363-2374.2002

M3 - Article

C2 - 11836414

AN - SCOPUS:0036168066

VL - 76

SP - 2363

EP - 2374

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 5

ER -